Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Retel VP"'
Publikováno v:
In Health policy December 2019 123(12):1185-1198
Autor:
Van 'T Veer, Laura, Drukker, CA, Nijenhuis, MV, Bueno-de-Mesquita, JM, Retel, VP, van, WH, van, H, Wesseling, J, Schmidt, MK, van't, LJ, Sonke, GS
Publikováno v:
Van 'T Veer, Laura; Drukker, CA; Nijenhuis, MV; Bueno-de-Mesquita, JM; Retel, VP; van, WH; et al.(2014). Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4st3j4pq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::33b8295d461ff21411922428737ec21c
http://www.escholarship.org/uc/item/4st3j4pq
http://www.escholarship.org/uc/item/4st3j4pq
Autor:
Van 'T Veer, Laura, Drukker, CA, Bueno-de-Mesquita, JM, Retel, VP, van, WH, van, H, Wesseling, J, Roumen, RMH, Knauer, M, van, LJ, Sonke, GS
Publikováno v:
Van 'T Veer, Laura; Drukker, CA; Bueno-de-Mesquita, JM; Retel, VP; van, WH; van, H; et al.(2013). A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/44q9v0p3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::93c2733fcad6a7d71416aebd4be5c95f
http://www.escholarship.org/uc/item/44q9v0p3
http://www.escholarship.org/uc/item/44q9v0p3
Publikováno v:
In Value in Health October-November 2017 20(9):A433-A434
Autor:
Leek LVM; Department of Medical Oncology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Notohardjo JCL; Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands., de Joode K; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Velker EL; Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., de Groot JWB; Department of Medical Oncology, Oncology Center Isala, Isala, Zwolle, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands., Westgeest HM; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Labots M; Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands., Voest EE; Department of Medical Oncology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., van de Haar J; Department of Medical Oncology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands. j.vd.haar@nki.nl., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands. vandeneertwegh@amsterdamumc.nl.
Publikováno v:
Scientific reports [Sci Rep] 2024 May 16; Vol. 14 (1), pp. 11244. Date of Electronic Publication: 2024 May 16.
Autor:
Ten Ham RMT; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Rohaan MW; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Jedema I; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kessels R; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Stegeman W; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Scheepmaker W; Financial Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Nuijen B; Division of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Nijenhuis C; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lindenberg M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Borch TH; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Monberg T; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Donia M; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Marie Svane I; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., van Harten W; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands V.retel@nki.nl.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 26; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 26.
Autor:
Klaassen-Dekker A; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands. a.klaassen@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.klaassen@iknl.nl., Drossaert CHC; Health & Technology Department, University of Twente, Enschede, The Netherlands., Van Maaren MC; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Utrecht, The Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Korevaar JC; Faculty of Health, Nutrition & Sport, The Hague University of Applied Sciences, The Hague, The Netherlands.; Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands., Siesling S; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Nov 14; Vol. 23 (1), pp. 1112. Date of Electronic Publication: 2023 Nov 14.
Autor:
Patel S; Department of Operating Rooms, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Lindenberg M; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer InstituteAntoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Rovers MM; Department of Operating Rooms, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Harten WH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer InstituteAntoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Ruers TJM; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Poot L; Department of Medical Technology, Isala Hospital, Zwolle, The Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer InstituteAntoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Grutters JPC; Department of Operating Rooms, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
International journal of health policy and management [Int J Health Policy Manag] 2022 Mar 01; Vol. 11 (3), pp. 299-307. Date of Electronic Publication: 2022 Mar 01.
Autor:
Koemans WJ; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands. w.koemans@nki.nl., van der Kaaij RT; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Boot H; Department of Gastro-Intestinal Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Buffart T; Department of Gastro-Intestinal Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Veenhof AAFA; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Hartemink KJ; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Grootscholten C; Department of Gastro-Intestinal Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Snaebjornsson P; Department of Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Retel VP; Department of Psychosocial Research and Epidomiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Vanhoutvin S; Department of Biometrics, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., van der Noort V; Department of Biometrics, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Houwink A; Department of Anaesthesiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Hahn C; Department of Anaesthesiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Lahaye M; Department of Radiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands., Los M; Department of Oncology, Sint Antonius Hospital, Koekoekslaan 1, Nieuwegein, 3435 CM, The Netherlands., van den Barselaar P; Clinical perfusion, Heartbeat, Kerkstraat 3A, Eemnes, 3755 CK, The Netherlands., Imhof O; Clinical perfusion, Heartbeat, Kerkstraat 3A, Eemnes, 3755 CK, The Netherlands., Aalbers A; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., van Dam GM; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands., van Etten B; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands., Wijnhoven BPL; Department of Surgery, Erasmus Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., Luyer MDP; Department of Surgery, Catharina Hospital, Michelangelolaan 2, Eindhoven, 5623 EJ, The Netherlands., Boerma D; Department of Surgery, Sint Antonius Hospital, Koekoekslaan 1, Nieuwegein, 3435 CM, The Netherlands., van Sandick JW; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands.
Publikováno v:
BMC cancer [BMC Cancer] 2019 May 06; Vol. 19 (1), pp. 420. Date of Electronic Publication: 2019 May 06.
Autor:
van Waalwijk van Doorn-Khosrovani SB; CZ Health Insurance, Tilburg., Pisters-van Roy A; CZ Health Insurance, Tilburg., van Saase L; National Health Care Institute (Zorginstituut Nederland), Diemen., van der Graaff M; National Health Care Institute (Zorginstituut Nederland), Diemen., Gijzen J; CZ Health Insurance, Tilburg., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam; Center for Personalised Cancer Treatment (CPCT)., Hoes LR; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam., van Berge Henegouwen JM; Division of Medical Oncology, Leiden University Medical Center, Leiden., van der Wijngaart H; Division of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam., van der Velden DL; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam., van Werkhoven E; Department of Biometrics, Netherlands Cancer Institute, Amsterdam., Retel VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam; Department of Health Technology and Services Research, University of Twente, Enschede., van Harten WH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam; Department of Health Technology and Services Research, University of Twente, Enschede; Rijnstate Hospital, Arnhem., Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Timmers L; National Health Care Institute (Zorginstituut Nederland), Diemen., Gelderblom H; Division of Medical Oncology, Leiden University Medical Center, Leiden., Verheul HMW; Division of Medical Oncology, Leiden University Medical Center, Leiden., Voest EE; Center for Personalised Cancer Treatment (CPCT); Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam. Electronic address: e.voest@nki.nl.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 May 01; Vol. 30 (5), pp. 663-665.